Sunshine Heart Pauses COUNTER HF Trial To Study Patient Deaths
This article was originally published in The Gray Sheet
Executive Summary
The COUNTER HF trial will temporarily stop enrolling patients because more than three of the first twenty study subjects have died, as specified in the study protocol. The company says it is working with FDA on a plan to restart the trial.